e-learning
resources
Stockholm 2002
Monday 16.09.2002
Death and severe exacerbations of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Influence of concomitant diseases on death rate of patients with COPD
R. I. Azimov (Tashkent, Uzbekistan)
Source:
Annual Congress 2002 - Death and severe exacerbations of COPD
Session:
Death and severe exacerbations of COPD
Session type:
Oral Presentation
Number:
1336
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. I. Azimov (Tashkent, Uzbekistan). Influence of concomitant diseases on death rate of patients with COPD. Eur Respir J 2002; 20: Suppl. 38, 1336
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
The influence of chronic concomitant diseases and age on the risk of death in patients with community-aquired pneumonia
Source: Eur Respir J 2002; 20: Suppl. 38, 354s
Year: 2002
Adherence to treatment strategies correlates with the annual rate of hospitalizations and 1-year mortality in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation
Year: 2010
Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia
Source: Eur Respir J 2014; 43: 36-42
Year: 2004
Role of comorbidities in stable COPD patients mortality
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016
Determinants of exacerbation rate in patients with stable COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 661s
Year: 2004
Effects of cardiovascular agents on respiratory function in COPD patients with concomitant coronary heart disease
Source: Eur Respir J 2002; 20: Suppl. 38, 247s
Year: 2002
Prevalence of comorbidities in patients with chronic obstructive pulmonary disease in presence of heart failure
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Coexisting cardiovascular diseases increase the risk of exacerbations in patients with COPD
Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity
Year: 2011
Impact of COVID-19 on patients with chronic lung disease
Source: Virtual Congress 2021 – COVID - 19 epidemiology
Year: 2021
Undiagnosed heart failure in elderly COPD patients does not affect the diffusion capacity
Source: Annual Congress 2008 - Lung function in respiratory disease
Year: 2008
Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD).
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
Incidence and outcome of lung cancer in patients with chronic respiratory failure
Source: International Congress 2019 – Biology and prognosis of lung cancer
Year: 2019
Factors affecting in-hospital mortality in patients with chronic obstructive pulmonary disease exacerbation
Source: Annual Congress 2013 –The latest insights in chronic care
Year: 2013
Factors affecting one year mortality of hospitalized patients with COPD exacerbation and respiratory failure
Source: Eur Respir J 2007; 30: Suppl. 51, 321s
Year: 2007
Changing causes of mortality for people with chronic respiratory diseases
Source: International Congress 2018 – COPD and chronic respiratory disease: from misclassification to radiological findings
Year: 2018
Relationship between heart rate variability and disease characteristics in patients with COPD
Source: Annual Congress 2008 - Rehabilitation and influencing factors
Year: 2008
Influence of pneumonia on the survival of patients with COPD
Source: Virtual Congress 2020 – Diagnosis and management of COPD
Year: 2020
Frequency of adverse consequences after spirography in patients with chronic obstructive pulmonary disease and concomitant ischemic heart disease
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
In hospitalized COPD exacerbation (COPDE) patients a 30-day readmission is associated with a progressive increased risk of mortality
Source: International Congress 2015 – COPD: interesting notes
Year: 2015
Prevalence and characteristics of congestive heart failure in elderly patients with chronic lung disease
Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept